CardioComm Solutions, Inc.

CardioComm Solutions, Inc.

May 11, 2009 10:34 ET

Acquisition of Shares of CardioComm Solutions, Inc.

TORONTO, ONTARIO--(Marketwire - May 11, 2009) - Dr. Anatoly Langer, the Chairman of CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm" or the "Company"), today announced that he acquired ownership of 1,250,000 common shares of the Company and control or direction over 625,000 common shares of the Company, representing in the aggregate approximately 4.1% of the issued and outstanding common shares of the Company. The shares were issued at an average price of approximately $0.03 per share pursuant to section 2.14 of National Instrument 45-106 - Prospectus and Registration Exemptions as compensation for management services provided to the Company in the first quarter of 2009.

Dr. Langer now owns or has control or direction over an aggregate of 18,298,081 common shares of the Company, representing approximately 40.2% of the Company's issued and outstanding common shares. In the future, Dr. Langer may receive further shares from the Company as compensation for the provision of management services. In addition, Dr. Langer has previously purchased shares from the Company for investment purposes, and in the future may further purchase, hold, vote, trade, dispose or otherwise deal in the common shares of the Company in such manner as he deems advisable to benefit from changes in market prices of such common shares, changes in the operations of the Company, its business strategy or prospects, or from a sale or merger of the Company.

Dr. Anatoly Langer

To review the report associated with this news release, please go to CardioComm's profile on SEDAR at

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Contact Information